Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Share-based Compensation: 2009-2025

Historic Share-based Compensation for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to $532,000.

  • Rockwell Medical's Share-based Compensation rose 65.73% to $532,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 54.34%. This contributed to the annual value of $1.3 million for FY2024, which is 38.63% up from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Share-based Compensation is $532,000, which was up 39.27% from $382,000 recorded in Q2 2025.
  • Rockwell Medical's Share-based Compensation's 5-year high stood at $532,000 during Q3 2025, with a 5-year trough of -$236,000 in Q1 2021.
  • Moreover, its 3-year median value for Share-based Compensation was $321,000 (2024), whereas its average is $325,727.
  • Per our database at Business Quant, Rockwell Medical's Share-based Compensation slumped by 125.24% in 2021 and then surged by 218.56% in 2023.
  • Quarterly analysis of 5 years shows Rockwell Medical's Share-based Compensation stood at $385,000 in 2021, then tumbled by 42.86% to $220,000 in 2022, then declined by 0.91% to $218,000 in 2023, then skyrocketed by 75.23% to $382,000 in 2024, then soared by 65.73% to $532,000 in 2025.
  • Its last three reported values are $532,000 in Q3 2025, $382,000 for Q2 2025, and $445,000 during Q1 2025.